The protective effect on cognitive abilities might originate from the reduction in seizures albeit the special efficacy of vigabatrin in TSC could partially be also due to its ability to directly inhibit the mTOR pathway [108]. The gene discussed is MTOR; the disease is tuberous sclerosis.